Rheum for Everyone, Episode 24 (video)| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Systemic Lupus Erythematosus

Researcher Looks for Clues to Help Treat Pediatric Lupus

Staff  |  September 1, 2011

With the support of the ACR Research and Education Foundation (REF) Awards and Grants program, Ornella Rullo, MD, has developed research that may help rheumatologists better treat pediatric patients.

T Cells in Systemic Lupus Erythematosus

Mindy S. Lo, MD, PhD, and George C. Tsokos, MD  |  August 1, 2011

Progress toward targeted therapy

How a Nuclear Molecule Alarms the Immune System

Deena A. Abdulahad, MD, and Marc Bijl, MD  |  August 1, 2011

The role of HMGB1 in the pathogenesis of lupus nephritis

Past Secrets for the Future of Lupus

David S. Pisetsky, MD, PhD  |  August 1, 2011

A stretch-limo ride with academic rheumatologists leads to reflection

A&R Abstracts – T CELLS

Staff  |  August 1, 2011

For Further Reading

A&R Abstracts – HMGB1

Staff  |  August 1, 2011

For Further Reading

How Energy Shifts Lead to Systemic Illness

Rainer H. Straub, MD  |  July 12, 2011

The impact of adaptive energy programs on the manifestations of chronic inflammatory disease

Hydroxychloroquine Retinopathy Still Alive and Well

Michael F. Marmor, MD  |  May 16, 2011

How rheumatologists are affected by new guidelines from ophthalmology

CARRA

Mary Desmond Pinkowish  |  May 16, 2011

Working for Children with Rheumatic Diseases

Lupus Patients Have More Lethal Form of Kidney Disease

Sue Pondrom  |  April 13, 2011

SLE patients with ESRD at increased risk of death

  • « Previous Page
  • 1
  • …
  • 40
  • 41
  • 42
  • 43
  • 44
  • …
  • 46
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences